MALATTIA DA REFLUSSO NON RESPONSIVA AI PPI! EVIDENCE- BASED CONCLUSIONI DEL GRUPPO INTERNAZIONALE PER LA ESOFAGITE. OCCHIO ALLA DIVERSA POTENZA DEI PPI! DA”ALIMENTARY PHARMACOLOGY & THERAPEUTICS” (FREE!)

DISORDINI FUNZIONALI, DISPEPSIA, ENDOSCOPIA, GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNA, NEWSLETTER

Management of Patients With Refractory Reflux-LikeSymptoms Despite Proton Pump Inhibitor Therapy:Evidence-Based Consensus Statements David Armstrong et al. on behalf of the International Working Group for the Classification of Oesophagitis (IWGCO) ABSTRACT Background Many patients diagnosed with gastro-oesophageal reflux disease (GERD) have persistent symptoms despite proton pump inhibitor (PPI) therapy. Aims The aim of this consensus…

TEST MOLECOLARI E TERAPIE TARGET PER IL CANCRO EPATOBILIARE. UNA SPLENDIDA REVIEW DA”JAMA SURGERY” (FREE!)

CHIRURGIA, DIAGNOSTICA PER IMMAGINI, ECOGRAFIA ED ECOENDOSCOPIA, EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, NEWSLETTER

Molecular Testing and Targeted Therapies in Hepatobiliary Cancers. A Review Diamantis I. Tsilimigras et al. Abstract Importance  Hepatobiliary cancers are heterogeneous and molecularly complex. Recent advances in next-generation sequencing (NGS) have enhanced the understanding of their molecular landscape and enabled deployment of biomarker-based gene- and immune-targeted therapies. This review examines the role of molecular testing and…

ATTENZIONE IBDOLOGI! OCCHIO ALL’AIUTO CHE L’INTELLIGENZA ARTIFICIALE PUO’ DARE PER LA PERSONALIZZAZIONE DELLA TERAPIA NELLE IBD: una revisione dal gruppo di Cork! DA “GASTROENTEROLOGY” (FREE!)

AI, INTELLIGENZA ARTIFICIALE, CHIRURGIA, GASTROENTEROLOGIA, IBD, METODOLOGIA, NEWSLETTER

AI-driven Personalized Medicine: Transforming Clinical Practice in Inflammatory Bowel Disease Marietta IacuccI et al. Abstract: Inflammatory bowel disease (IBD) is marked by significant clinical heterogeneity, posing challenges for accurate diagnosis and personalized treatment strategies. Conventional approaches, such as endoscopy and histology, often fail to adequately and accurately predict medium and long-term outcomes, leading to suboptimal…

LESIONI PERCANCEROSE DELLO STOMACO: LE ULTIME LINEE GUIDA EUROPEE ! ATTENZIONE GASTROENTEROLOGI! DA “ENDOSCOPY” (FREE!)

ENDOSCOPIA, GASTROENTEROLOGIA, NEWSLETTER, ONCOLOGIA

Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025 Mário Dinis-Ribeiro et al. Main Recommendations At a population level, the European Society of Gastrointestinal Endoscopy (ESGE), the European Helicobacter and Microbiota…

MICROBIOTA: DAL MACHINE LEARNING NELL’APPROCCIO MULTI-OMICS ALLA CLINICA ! UNA OTTIMA REVISIONE DEL GRUPPO DELLA CATTOLICA. DA “GASTROENTEROLOGY” (FREE!)

AI, INTELLIGENZA ARTIFICIALE, GASTROENTEROLOGIA, MEDICINA DEI PROBIOTICI, METODOLOGIA

Machine learning and artificial intelligence in the multi-omics approach to gut microbiota Tommaso Rozera et al. ABSTRACT The gut microbiome is involved in human health and disease, and its comprehensive understanding is necessary to exploit it as a diagnostic or therapeutic tool. Multi-omics approaches, including metagenomics, metatranscriptomics, metabolomics, and metaproteomics, enable depicting the complexity of…

EPATITE DA VIRUS B: UN GRANDE SUPPLEMENTO DEL “JOURNAL OF VIRAL HEPATITIS” (FREE!)

EPATOLOGIA, EPATOLOGIA ONCOLOGICA, NEWSLETTER

Journal of Viral Hepatitis: Volume 31, Issue S2 Pages: 1-60 December 2024 Previous Issue|Next Issue Export Citation(s) The publication of this supplement has been funded by Gilead ISSUE INFORMATION   Free Access Global elimination of HBV: Is it really achievable? Erwan Vo-Quang,  Maud Lemoine Pages: 4-12 First Published: 26 May 2024 Abstract Full text PDF References Request permissions   Free Access…